Advances in malignant mesothelioma BWS Robinson, RA Lake New England Journal of Medicine 353 (15), 1591-1603, 2005 | 1276 | 2005 |
Malignant mesothelioma BWS Robinson, AW Musk, RA Lake The Lancet 366 (9483), 397-408, 2005 | 962 | 2005 |
Immunotherapy and chemotherapy—a practical partnership RA Lake, BWS Robinson Nature Reviews Cancer 5 (5), 397-405, 2005 | 786 | 2005 |
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ... Nature genetics 43 (7), 668-672, 2011 | 775 | 2011 |
Mesothelin-family proteins and diagnosis of mesothelioma BWS Robinson, J Creaney, R Lake, A Nowak, AW Musk, N de Klerk, ... The Lancet 362 (9396), 1612-1616, 2003 | 653 | 2003 |
Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells AK Nowak, RA Lake, AL Marzo, B Scott, WR Heath, EJ Collins, ... The Journal of Immunology 170 (10), 4905-4913, 2003 | 524 | 2003 |
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors AK Nowak, BWS Robinson, RA Lake Cancer research 63 (15), 4490-4496, 2003 | 497 | 2003 |
Tumor-specific CD4+ T cells have a major “post-licensing” role in CTL mediated anti-tumor immunity AL Marzo, BF Kinnear, RA Lake, JJ Frelinger, EJ Collins, BWS Robinson, ... The Journal of Immunology 165 (11), 6047-6055, 2000 | 482 | 2000 |
Programmed death ligand 2 in cancer-induced immune suppression EN Rozali, SV Hato, BW Robinson, RA Lake, WJ Lesterhuis Journal of Immunology Research 2012, 2012 | 376 | 2012 |
Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy AK Nowak, BWS Robinson, RA Lake Cancer research 62 (8), 2353-2358, 2002 | 284 | 2002 |
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity WJ Lesterhuis, A Bosco, MJ Millward, M Small, AK Nowak, RA Lake Nature Reviews Drug Discovery 16 (4), 264-272, 2017 | 214 | 2017 |
Tumor antigens are constitutively presented in the draining lymph nodes AL Marzo, RA Lake, D Lo, L Sherman, A McWilliam, D Nelson, ... The Journal of Immunology 162 (10), 5838-5845, 1999 | 200 | 1999 |
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment RM Zemek, E De Jong, WL Chin, IS Schuster, VS Fear, TH Casey, ... Science translational medicine 11 (501), eaav7816, 2019 | 184 | 2019 |
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice WJ Aston, DE Hope, AK Nowak, BW Robinson, RA Lake, WJ Lesterhuis BMC cancer 17, 1-10, 2017 | 182 | 2017 |
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity WJ Lesterhuis, J Salmons, AK Nowak, EN Rozali, A Khong, IM Dick, ... PloS one 8 (4), e61895, 2013 | 171 | 2013 |
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors AL Marzo, RA Lake, BWS Robinson, B Scott Cancer Research 59 (5), 1071-1079, 1999 | 163 | 1999 |
A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis FJH Brims, TM Meniawy, I Duffus, D de Fonseka, A Segal, J Creaney, ... Journal of Thoracic Oncology 11 (4), 573-582, 2016 | 162 | 2016 |
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents AK Nowak, RA Lake, HL Kindler, BWS Robinson Seminars in oncology 29 (1), 82-96, 2002 | 160 | 2002 |
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting … RG Van Der Most, AJ Currie, S Mahendran, A Prosser, A Darabi, ... Cancer Immunology, Immunotherapy 58, 1219-1228, 2009 | 154 | 2009 |
Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation S Mukherjee, T Haenel, R Himbeck, B Scott, I Ramshaw, RA Lake, ... Cancer Gene Therapy 7 (5), 663-670, 2000 | 136 | 2000 |